Core Laboratories (CLB) Non-Current Deferred Tax Liability (2022 - 2026)

Core Laboratories has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $8.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 18.48% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $8.1 million (down 18.48% YoY), and the FY2025 full-year result was $8.0 million, down 11.81% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $8.1 million, up from $8.0 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $22.9 million in Q4 2022, with the low at $8.0 million in Q4 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $12.0 million across 5 years, with a median of $11.9 million in 2023.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability slumped 44.5% — and 2024, when it grew 14.01%.
• Core Laboratories' Non-Current Deferred Tax Liability stood at $22.9 million in 2022, then slumped by 44.5% to $12.7 million in 2023, then declined by 28.6% to $9.1 million in 2024, then fell by 11.81% to $8.0 million in 2025, then rose by 0.98% to $8.1 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $8.1 million (Q1 2026), $8.0 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.